15.265 articles found

The Effects of Functional Training, Bicycle Exercise, and Exergaming on Walking Capacity of Elderly Patients With Parkinson Disease: A Pilot Randomized Controlled Single-blinded Trial.

Ferraz DD, Trippo KV, Duarte GP, Neto MG, Bernardes Santos KO, Filho JO.

Arch Phys Med Rehabil · 2018-01-11

DOI: 10.1016/j.apmr.2017.12.014PMID: 29337023

Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).

Sackley CM, Smith CH, Rick CE, Brady MC, Ives N, Patel S, Woolley R, Dowling F, Patel R, Roberts H, Jowett S, Wheatley K, Kelly D, Sands G, Clarke CE, PD COMM Pilot Collaborative Group.

Pilot Feasibility Stud · 2018-01-10

DOI: 10.1186/s40814-017-0222-zPMID: 29344405

Aerobic exercise is more effective than goal-based exercise for the treatment of cognition in Parkinson's disease.

Silveira CRA, Roy EA, Intzandt BN, Almeida QJ.

Brain Cogn · 2018-01-10

DOI: 10.1016/j.bandc.2018.01.002PMID: 29331916

Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson's progression: Evidence from clinical studies and neurotoxin models.

Johnson ME, Salvatore MF, Maiolo SA, Bobrovskaya L.

Prog Neurobiol · 2018-01-10

DOI: 10.1016/j.pneurobio.2018.01.002PMID: 29331395

Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: a randomised controlled study.

Ferrazzoli D, Ortelli P, Zivi I, Cian V, Urso E, Ghilardi MF, Maestri R, Frazzitta G.

J Neurol Neurosurg Psychiatry · 2018-01-10

DOI: 10.1136/jnnp-2017-316437PMID: 29321141

Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications.

El Harrad L, Bourais I, Mohammadi H, Amine A.

Sensors (Basel) · 2018-01-09

DOI: 10.3390/s18010164PMID: 29315246

Neurotoxins as Preclinical Models for Parkinson's Disease.

Segura-Aguilar J.

Neurotox Res · 2018-01-08

DOI: 10.1007/s12640-017-9856-0PMID: 29313219

Familial tauopathy with P364S MAPT mutation: clinical course, neuropathology and ultrastructure of neuronal tau inclusions.

Štrafela P, Pleško J, Magdič J, Koritnik B, Zupan A, Glavač D, Bresjanac M, Popović M.

Neuropathol Appl Neurobiol · 2018-01-07

DOI: 10.1111/nan.12456PMID: 29215752

Goal-orientated cognitive rehabilitation for dementias associated with Parkinson's disease-A pilot randomised controlled trial.

Hindle JV, Watermeyer TJ, Roberts J, Brand A, Hoare Z, Martyr A, Clare L.

Int J Geriatr Psychiatry · 2018-01-04

DOI: 10.1002/gps.4845PMID: 29314218

Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose.

Aranda-Barradas ME, Márquez M, Quintanar L, Santoyo-Salazar J, Espadas-Álvarez AJ, Martínez-Fong D, García-García E.

Pharmaceutics · 2018-01-03

DOI: 10.3390/pharmaceutics10010005PMID: 29301386

Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists.

Elson MJ, Stevenson EA, Feldman BA, Lim J, Beck CA, Beran DB, Schmidt PN, Biglan KM, Simone R, Willis AW, Dorsey ER, Boyd CM.

Telemed J E Health · 2018-01-03

DOI: 10.1089/tmj.2017.0210PMID: 29297769

Are patients with Parkinson's disease who have either mild to moderate microsmia, severe microsmia or anosmia clinically different?

Cox CM.

· 2018-01-01